US 11673896
Pyridine compounds as allosteric SHP2 inhibitors
granted A61PA61P35/00
Quick answer
US patent 11673896 (Pyridine compounds as allosteric SHP2 inhibitors) held by Revolution Medicines, Inc. expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Revolution Medicines, Inc.
- Grant date
- Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P35/00